Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric Cancer
Clinical trial NCT02004769 · COMPLETED
Trial details
- NCT number
- NCT02004769
- Sponsor
- Sun Yat-sen University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2016-06-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.